Published on

Medicine – Clinical Risk Factors for Deep Vein Thrombosis (DVT)

Deep vein thrombosis (DVT) is the formation of a blood clot within a deep vein, most commonly affecting the lower limbs. It is an important manifestation of venous thromboembolism (VTE), which also includes pulmonary embolism (PE).

DVT develops when one or more factors promote venous stasis, endothelial injury or increased blood coagulability.

Important Clinical Principle

The risk factors for DVT are best understood using Virchow's triad: venous stasis, endothelial injury and hypercoagulability.

1. Virchow's Triad

Virchow's triad describes three major mechanisms that contribute to venous thrombosis.

  1. Venous stasis: Reduced or sluggish venous blood flow.
  2. Endothelial injury: Damage to the lining of blood vessels.
  3. Hypercoagulability: Increased tendency of blood to form clots.

Illustration: Virchow's Triad

Venous Stasis Endothelial Injury Hyper- coagulability DVT

Virchow's triad: three interacting mechanisms contributing to venous thrombosis.

A. Venous Stasis

Reduced venous blood flow allows coagulation factors to accumulate and promotes thrombus formation.

  • Prolonged immobility.
  • Bed rest and hospitalisation.
  • Paralysis following stroke.
  • Heart failure.
  • Long-distance travel with prolonged sitting.
  • Postoperative immobilisation.

B. Endothelial Injury

Damage to the venous endothelium activates coagulation and facilitates thrombus formation.

  • Major abdominal or pelvic surgery.
  • Orthopaedic surgery.
  • Lower-limb trauma.
  • Bone fractures.
  • Major tissue injury.
  • Venous catheterisation or vascular instrumentation.

C. Hypercoagulability

Hypercoagulability refers to an increased tendency of blood to clot and may be inherited or acquired.

Inherited causes:

  • Factor V Leiden mutation.
  • Prothrombin G20210A mutation.
  • Protein C deficiency.
  • Protein S deficiency.
  • Antithrombin deficiency.

Acquired causes:

  • Malignancy.
  • Pregnancy and puerperium.
  • Oestrogen-containing contraception or hormone therapy.
  • Antiphospholipid syndrome.
  • Nephrotic syndrome.
  • Myeloproliferative neoplasms.

2. Clinical Risk Factors for DVT

A. Increasing Age

The incidence of DVT increases with age because of changes in coagulation, reduced mobility and the increasing prevalence of comorbidities.

B. Immobility

Immobility reduces the action of the calf muscle pump and causes venous stasis in the lower limbs.

Examples include prolonged bed rest, paralysis, hospitalisation and prolonged sitting during travel.

C. Major Surgery

Major abdominal, pelvic and orthopaedic operations increase DVT risk through endothelial injury, postoperative immobility and activation of the coagulation system.

The risk is particularly important following major lower-limb orthopaedic procedures.

D. Malignancy

Cancer can produce a hypercoagulable state through tumour-associated procoagulant activity, inflammation and interactions with the coagulation system.

The risk is particularly important in patients with active malignancy, including pancreatic and other adenocarcinomas.

Cancer-associated thrombosis may be related to Trousseau syndrome, classically associated with migratory thrombophlebitis.

E. Lower-Limb Trauma

Lower-limb fractures and major trauma increase DVT risk through endothelial injury, inflammation and immobilisation.

F. Hormonal Factors

Pregnancy and Puerperium

Pregnancy produces a physiological hypercoagulable state and may reduce venous return because of compression of pelvic veins.

The risk of VTE is particularly increased during the postpartum period.

Oestrogen and Oral Contraceptive Treatment

Oestrogen-containing combined oral contraceptives and certain hormone therapies increase the risk of venous thrombosis.

The risk is influenced by the type of hormonal preparation and individual patient factors.

G. Myocardial Infarction and Stroke

Patients hospitalised following myocardial infarction or stroke may develop DVT because of immobility, reduced mobility and associated cardiovascular dysfunction.

Stroke with paralysis is particularly important because of impaired lower-limb muscle pumping.

H. Inherited Thrombophilia

Inherited thrombophilias are genetic abnormalities that increase the tendency to develop venous thrombosis.

Inherited Disorder Mechanism
Factor V Leiden Resistance to activated protein C
Protein C deficiency Reduced physiological anticoagulant activity
Protein S deficiency Reduced protein C cofactor activity
Antithrombin deficiency Reduced inhibition of thrombin and factor Xa
Prothrombin G20210A Increased prothrombin levels

I. Previous VTE and Family History

A personal history of previous DVT or pulmonary embolism is an important predictor of recurrent VTE.

A family history of thrombosis, particularly in a first-degree relative, may indicate inherited susceptibility.

J. Obesity

Obesity increases VTE risk through reduced venous return, inflammation and associated prothrombotic changes.

K. Increased Blood Viscosity

Certain disorders associated with increased blood viscosity or abnormal blood-cell production may contribute to thrombosis.

Examples include polycythaemia vera and other myeloproliferative neoplasms.

L. Cigarette Smoking

Smoking is associated with vascular and prothrombotic effects. Its independent contribution to DVT risk is generally smaller and less consistent than that of major surgery, active malignancy or previous VTE.

M. Hyperosmolar Hyperglycaemic State

The hyperosmolar hyperglycaemic state may increase thrombosis risk through severe dehydration, haemoconcentration, inflammation and immobility.

N. Varicose Veins

Varicose veins are associated with venous dysfunction and may be a marker of increased VTE risk, although the strength of their independent association varies.

O. Nephrotic Syndrome

Nephrotic syndrome causes an acquired hypercoagulable state through urinary loss of anticoagulant proteins, increased hepatic synthesis of procoagulant factors and other haemostatic changes.

Venous thrombosis, including renal vein thrombosis, is an important complication.

3. Mind Map – Clinical Risk Factors for DVT

The following mind map organises the major risk factors according to Virchow's triad.

DVT Risk Factors Virchow's Triad Venous Stasis Endothelial Injury • Increasing age • Immobility / bed rest • Stroke with paralysis • Heart failure • Prolonged travel / sitting • Major abdominal surgery • Orthopaedic surgery • Lower-limb trauma • Bone fractures • Vascular instrumentation Hypercoagulability Inherited Acquired • Factor V Leiden • Prothrombin mutation • Protein C deficiency • Protein S deficiency • Antithrombin deficiency • Family history of VTE • Cancer and obesity • Pregnancy / puerperium • Oestrogen therapy • Nephrotic syndrome • Antiphospholipid syndrome • Myeloproliferative disease

Mind map of the major DVT risk factors. Several risk factors contribute through more than one mechanism. Previous VTE is an important predictor of recurrence.

4. High-Yield Clinical Associations

Clinical Scenario Important Mechanism
Postoperative patient confined to bedStasis, endothelial injury and hypercoagulability
Pancreatic adenocarcinomaCancer-associated hypercoagulability
Pregnancy and puerperiumIncreased coagulation factors and reduced venous return
Combined oral contraceptive useOestrogen-associated hypercoagulability
Nephrotic syndromeLoss of anticoagulant proteins and other prothrombotic changes
Factor V LeidenResistance to activated protein C
Antiphospholipid syndromeAcquired autoimmune thrombophilia
Previous DVT or PEIncreased risk of recurrent VTE

5. Important Risk Factors to Remember

Major Risk Factors
  • Previous DVT or pulmonary embolism.
  • Major surgery and significant trauma.
  • Prolonged immobility or paralysis.
  • Active malignancy.
  • Pregnancy and the postpartum period.
  • Inherited or acquired thrombophilia.

Other contributing factors include increasing age, obesity, oestrogen exposure, heart failure, nephrotic syndrome, hyperosmolar hyperglycaemic state, smoking and venous disease.

6. Key Examination Pearls

  • Virchow's triad consists of venous stasis, endothelial injury and hypercoagulability.
  • Major surgery, immobility, active malignancy and previous VTE are particularly important risk factors.
  • Pancreatic and other mucin-producing adenocarcinomas may be associated with thrombosis.
  • Pregnancy and the puerperium increase VTE risk, particularly during the postpartum period.
  • Factor V Leiden causes resistance to activated protein C.
  • Protein C, protein S and antithrombin deficiencies increase thrombotic risk.
  • Nephrotic syndrome causes an acquired hypercoagulable state.
  • Stroke with paralysis increases DVT risk through venous stasis.
  • Antiphospholipid syndrome is an important acquired cause of thrombophilia.
  • A previous history of VTE is an important predictor of recurrence.
Most Important Examination Point

DVT risk factors can be classified using Virchow's triad. Major surgery, prolonged immobility, malignancy, pregnancy, oestrogen therapy, previous VTE and thrombophilia are particularly important clinical associations.

Clinical Note

Risk factors alone do not establish a diagnosis of DVT. Suspected DVT requires assessment of clinical probability and appropriate investigations, including D-dimer testing or compression ultrasonography. Sudden breathlessness, chest pain, syncope or haemodynamic instability may indicate pulmonary embolism and require urgent medical assessment.

Kembara Xtra – Medicine Revision Notes

Image description
0 Comments